| Subclinical hyperthyroidism: clinical features and treatment options B Biondi, EA Palmieri, M Klain, M Schlumberger, S Filetti, G Lombardi European Journal of Endocrinology 152 (1), 1-9, 2005 | 355 | 2005 |
| Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma A Bachelot, AF Cailleux, M Klain, E Baudin, M Ricard, N Bellon, B Caillou, ... Thyroid 12 (8), 707-711, 2002 | 225 | 2002 |
| The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses S Maurea, M Klain, C Mainolfi, M Ziviello, M Salvatore Journal of Nuclear Medicine 42 (6), 884-892, 2001 | 159 | 2001 |
| Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status L Tauchmanova, R Pivonello, C Di Somma, R Rossi, MC De Martino, ... The Journal of Clinical Endocrinology & Metabolism 91 (5), 1779-1784, 2006 | 157 | 2006 |
| Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males C Di Somma, A Colao, A Di Sarno, M Klain, ML Landi, G Facciolli, ... The Journal of Clinical Endocrinology & Metabolism 83 (3), 807-813, 1998 | 152 | 1998 |
| Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization A Colao, C Di Somma, S Loche, A Di Sarno, M Klain, R Pivonello, ... Clinical Endocrinology 52 (3), 319-327, 2000 | 140 | 2000 |
| Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study C Di Somma, R Pivonello, S Loche, A Faggiano, M Klain, M Salvatore, ... Clinical Endocrinology 58 (3), 302-308, 2003 | 129 | 2003 |
| Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases G Storto, M Klain, G Paone, R Liuzzi, L Molino, A Marinelli, A Soricelli, ... Bone 39 (1), 35-41, 2006 | 105 | 2006 |
| Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease C Di Somma, A Colao, R Pivonello, M Klain, A Faggiano, FS Tripodi, ... Clinical Endocrinology 48 (5), 655-662, 1998 | 105 | 1998 |
| Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response. C Ciacci, L Maurelli, M Klain, G Savino, M Salvatore, G Mazzacca, ... American Journal of Gastroenterology (Springer Nature) 92 (6), 1997 | 100 | 1997 |
| Radioiodine therapy for papillary and follicular thyroid carcinoma M Klain, M Ricard, S Leboulleux, E Baudin, M Schlumberger European Journal of Nuclear Medicine and Molecular Imaging 29, S479-S485, 2002 | 90 | 2002 |
| Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation A Schmidt, L Iglesias, M Klain, F Pitoia, MJ Schlumberger Archives of endocrinology and metabolism 61, 81-89, 2017 | 88 | 2017 |
| Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases G Conzo, D Pasquali, G Bellastella, K Esposito, C Carella, A De Bellis, ... Endocrine 44, 419-425, 2013 | 84 | 2013 |
| Severe impairment of bone mass and turnover in Cushing’s disease: comparison between childhood‐onset and adulthood‐onset disease C Di Somma, R Pivonello, S Loche, A Faggiano, P Marzullo, A Di Sarno, ... Clinical Endocrinology 56 (2), 153-158, 2002 | 81 | 2002 |
| The use of recombinant human TSH in the follow‐up of differentiated thyroid cancer: experience from a large patient cohort in a single centre V Giovanni, LG Arianna, C Antonio, F Francesco, K Michele, S Giovanni, ... Clinical Endocrinology 56 (2), 247-252, 2002 | 80 | 2002 |
| Treatment of refractory thyroid cancer A Berdelou, L Lamartina, M Klain, S Leboulleux, M Schlumberger Endocrine-related cancer 25 (4), R209-R223, 2018 | 77 | 2018 |
| Combined evaluation of regional coronary artery calcium and myocardial perfusion by 82Rb PET/CT in the identification of obstructive coronary artery disease E Zampella, W Acampa, R Assante, C Nappi, V Gaudieri, CG Mainolfi, ... European journal of nuclear medicine and molecular imaging 45, 521-529, 2018 | 64 | 2018 |
| Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours S Maurea, M Klain, C Caraco, M Ziviello, M Salvatore Nuclear medicine communications 23 (10), 951-960, 2002 | 50 | 2002 |
| Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation B Salvatore, G Paone, M Klain, G Storto, E Nicolai, D D'Amico, ... QJ Nucl Med Mol Imaging 52 (1), 2, 2008 | 49 | 2008 |
| Impairment of bone status in patients with central diabetes insipidus R Pivonello, A Colao, C Di Somma, G Facciolli, M Klain, A Faggiano, ... The Journal of Clinical Endocrinology & Metabolism 83 (7), 2275-2280, 1998 | 46 | 1998 |
